Navigation
banner

All posts by GTCbio

2017

GTCbio is excited to partner with Midwest Stem Cell Therapy Center at Kansas University Medical Center for 5th Annual Midwest Conference on Cell Therapy and Regenerative Medicine

GTCbio | August 30th, 2017

The Midwest Stem Cell Therapy Center (MSCTC) was established in 2013 to serve as a regional hub to facilitate stem cell research and clinical development. Since its inception, MSCTC has made significant progress in the adult stem cell field. A key goal of MSCTC is to educate regional and national stem cell enthusiasts about the…read more

Finalists Announced for the New Company/Technology Pitch Competition at the CNS Diseases Summit

GTCbio | August 25th, 2017

GTCbio is excited to announce the finalists for the inaugural new company/technology pitch competition at the CNS Diseases summit scheduled for Sep 11-12, 2017 in Boston. The following companies will compete for the “Most Promising New Technology” award and $5000 monetary prize. Orion BioScience – developing innovative therapies to cure autoimmune diseases using a soluble…read more

CRISPR & Genome Engineering

GTCbio | August 16th, 2017

CRISPR (Clusters of Regularly Interspaced Short Palindromic Repeats) is a specialized region of DNA comprised of two distinct characteristics including presence of nucleotide repeats and spacers. The term CRISPR is used interchangeably with CRISPR-Cas9. Cas9 (CRISPR-associated) is a protein that acts like molecular scissors cutting strands of DNA. It is basically a system inherent in…read more

Experimental Therapeutics & Approaches in Alzheimer’s Disease & Related Dementias

GTCbio | August 3rd, 2017

Alzheimer’s disease (AD), is a chronic neurodegenerative disease that usually starts slowly and worsens over time and although often appearing in people over 65 years of age, it is not just a disease of old age. It is estimated that approximately 200,000 Americans under the age of 65 have “early-onset” AD. It is believed that…read more